Laboratory value associations with LDH in sickle cell disease
Interpretation, variable . | No. . | r . | P . |
---|---|---|---|
Hemolysis | |||
Hemoglobin | 212 | -0.56 | <.001 |
Plasma hemoglobin | 170 | 0.45 | <.001 |
Reticulocyte count | 202 | 0.43 | <.001 |
Haptoglobin | 167 | -0.26 | .001 |
Hemoglobin S | 212 | 0.36 | <.001 |
Arginase | 119 | 0.35 | <.001 |
Hemolysis plus hepatic | |||
AST | 213 | 0.74 | <.001 |
Indirect bilirubin | 213 | 0.55 | <.001 |
Direct bilirubin | 213 | 0.55 | <.001 |
Hepatic | |||
ALT | 213 | 0.34 | <.001 |
Hepatic plus bone | |||
Alkaline phosphatase | 213 | 0.17 | .01 |
Leukocytes | |||
Leukocyte count | 212 | 0.34 | <.001 |
Muscle | |||
Creatine kinase | 212 | -0.14 | .04 |
Renal | |||
Creatinine | 213 | -0.10 | .1 |
Endothelial activation | |||
Soluble VCAM-1 | 161 | 0.38 | <.001 |
Soluble ICAM-1 | 155 | 0.16 | .04 |
Soluble E-selectin | 152 | 0.28 | .001 |
Soluble P-selectin | 157 | 0.16 | .04 |
Pulmonary | |||
Oxygen saturation | 142 | -0.44 | <.001 |
Interpretation, variable . | No. . | r . | P . |
---|---|---|---|
Hemolysis | |||
Hemoglobin | 212 | -0.56 | <.001 |
Plasma hemoglobin | 170 | 0.45 | <.001 |
Reticulocyte count | 202 | 0.43 | <.001 |
Haptoglobin | 167 | -0.26 | .001 |
Hemoglobin S | 212 | 0.36 | <.001 |
Arginase | 119 | 0.35 | <.001 |
Hemolysis plus hepatic | |||
AST | 213 | 0.74 | <.001 |
Indirect bilirubin | 213 | 0.55 | <.001 |
Direct bilirubin | 213 | 0.55 | <.001 |
Hepatic | |||
ALT | 213 | 0.34 | <.001 |
Hepatic plus bone | |||
Alkaline phosphatase | 213 | 0.17 | .01 |
Leukocytes | |||
Leukocyte count | 212 | 0.34 | <.001 |
Muscle | |||
Creatine kinase | 212 | -0.14 | .04 |
Renal | |||
Creatinine | 213 | -0.10 | .1 |
Endothelial activation | |||
Soluble VCAM-1 | 161 | 0.38 | <.001 |
Soluble ICAM-1 | 155 | 0.16 | .04 |
Soluble E-selectin | 152 | 0.28 | .001 |
Soluble P-selectin | 157 | 0.16 | .04 |
Pulmonary | |||
Oxygen saturation | 142 | -0.44 | <.001 |
Spearman correlation coefficients (r) and 2-tailed P values show degree of correlation of serum LDH level with various laboratory markers in a population of 213 patients with all forms of sickle cell disease.